Immunohistochemistry (IHC) Market - Global Industry Analysis, Market Size, Opportunities and Forecast, 2018 - 2026

Pune, India -- (SBWire) -- 02/16/2019 --The global Immunohistochemistry (IHC) market size is anticipated to around USD 3.7 billion by 2026, this market is anticipated to grow with 8.5% CAGR during the forecast time period. Developing predominance of malignant growth and different maladies worldwide with Immunohistochemistry (IHC) change base is required to drive the market amid the conjecture time frame. Also, surge in need for better health related solution and diagnostic service drive the global Immunohistochemistry (IHC) market during the coming years.

Free Download Sample Report Pages For Better understanding@ https://www.acumenresearchandconsulting.com/request-sample/1118

High pervasiveness of malignant growth and expanding medicinal services costs driven by extending maturing populace base are perceived as the most powerful factors driving the market.

Cancer has high bleakness and mortality chance. Conclusion of this sickness significantly relies upon the phase of the malady at affirmation. This has prompted popularity of immunohistochemistry (IHC) items. IHC recoloring process is performed on malignant growth tissues to uncover the nearness of HER2 receptors or potentially hormone receptors on their surface. This data assumes a fundamental job in arranging malignant growth treatment. This factor is foreseen to drive request in not so distant future. What's more, rising notoriety of focused immunotherapy and biologic treatment for anticancer medication improvement and expanding Food and Drug Administration (FDA) endorsements are required to help showcase development in not so distant future.

Noteworthy ascent in healthcare spending and move in spotlight on esteem based medicinal services arrangements can additionally prompt development of the immunohistochemistry showcase over the gauge time frame. As indicated by the Centers of Medicare and Medicaid Services (CMS) projections, the National Health Expenditure is foreseen to ascend at a normal of 5.5% consistently from 2017 to 2026. It is relied upon to stretch around USD 5.7 trillion by 2026. Clinics and care offices are embracing an increasingly explicit and focused on treatment for better results and to build up a move esteem based healthcare conveyance.

Asia Pacific is evaluated to observe the quickest development over the estimate time frame attributable to rising disposable income, high neglected clinical requirements of patients, rising mindfulness about early finding, and accessibility of successful treatment in rising nations, for example, India and China. Asia Pacific is the most encouraging goal for market players because of expanding instances of different sorts of cancers growths in this region. North America was at the front line of the market, with an offer of about 38.0% in 2018. Governments in the particular region are empowering continuous research exercises on Immunohistochemistry (IHC) by financing them. Other than this, nearness of cutting edge medicinal services offices and ceaseless headways in analytic methods are animating the development of the provincial market. The market in North America is likewise evaluated to be driven by developing geriatric populace and high acknowledgment for innovatively propelled facilities.

View Detail Information With Complete TOC@ https://www.acumenresearchandconsulting.com/immunohistochemistry-ihc-market

The global Immunohistochemistry (IHC) market is segmented into product, end-use, application, and region.On the basis of product, the global Immunohistochemistry (IHC) market is segmented into Antibodies (Primary Antibodies and secondary Antibodies), Equipment (Slide Staining Systems, Tissue Microarrays, Tissue Processing Systems, Slide Scanners, and Others) Reagents (Histological Stains, Blocking Sera and Reagents, Chromogenic Substrates, Fixation Reagents, Stabilizers, Organic Solvents, Proteolytic Enzymes, and Diluents) and Kits. On the basis of end-use, the global Immunohistochemistry (IHC) market is segmented into hospitals and diagnostic laboratories, research institutes, and others. On the basis of application, the global Immunohistochemistry (IHC) market is segmented into Drug testing and diagnostics. The diagnostics segment is further bifurcated into Cancer, Infectious Diseases, Cardiovascular Diseases, Autoimmune Diseases, Diabetes Mellitus, and Nephrological Diseases. On the basis of region the global Immunohistochemistry (IHC) market is bifurcated into Europe, Latin America, North America, Middle East & Africa, and Asia Pacific.

Different variables driving the immunohistochemistry market incorporate quick increment in social insurance spending and a changing healthcare foundation with better therapeutic practice and care offices. Maturing is related with contaminations and immune system illnesses because of a debilitating insusceptible framework. Ascend in geriatric populace prompts expanded requirement for IHC procedures, in this manner driving the Immunohistochemistry (IHC) market.

The key players catering to the global Immunohistochemistry (IHC) s market areF. Hoffmann-La Roche AG,Abcam plc,Thermo Fisher Scientific, Inc., Agilent Technologies, PerkinElmer, Inc., Bio SB, Merck KGaA, Bio-Rad Laboratories, Inc., Danaher Corporation, and Cell Signaling Technology, Inc. Significant strategic initiatives undertaken by global businesses include partnerships, new product launch, acquisitions.

Table Of Contents:

CHAPTER 1. INDUSTRY OVERVIEW

1.1. Definition and Scope
1.1.1. Definition of Immunohistochemistry (IHC)
1.1.2. Market Segmentation
1.1.3. List of Abbreviations
1.2. Summary
1.2.1. Market Snapshot
1.2.2. Immunohistochemistry (IHC) Market By Product
1.2.2.1. Global Immunohistochemistry (IHC) Market Revenue and Growth Rate Comparison By Product (2015-2026)
1.2.2.2. Global Immunohistochemistry (IHC) Market Revenue Share By Product in 2017
1.2.2.3. Antibodies
1.2.2.4. Equipment
1.2.2.5. Reagents
1.2.2.6. Kits
1.2.2.7. Others
1.2.3. Immunohistochemistry (IHC) Market By Application
1.2.3.1. Global Immunohistochemistry (IHC) Market Revenue and Growth Rate Comparison By Application (2015-2026)
1.2.3.2. Diagnostics
1.2.3.3. Drug Testing
1.2.3.4. Others
1.2.4. Immunohistochemistry (IHC) Market By End Users
1.2.4.1. Global Immunohistochemistry (IHC) Market Revenue and Growth Rate Comparison By End Users (2015-2026)
1.2.4.2. Hospitals and Diagnostic Laboratories
1.2.4.3. Research Institutes
1.2.4.4. Others
1.2.5. Immunohistochemistry (IHC) Market by Geography
1.2.5.1. Global Immunohistochemistry (IHC) Market Revenue and Growth Rate Comparison by Geography (2015-2026)
1.2.5.2. North America Immunohistochemistry (IHC) Market Revenue and Growth Rate (2015-2026)
1.2.5.3. Europe Immunohistochemistry (IHC) Market Revenue and Growth Rate (2015-2026)
1.2.5.4. Asia-Pacific Immunohistochemistry (IHC) Market Revenue and Growth Rate (2015-2026)
1.2.5.5. Latin America Immunohistochemistry (IHC) Market Revenue and Growth Rate (2015-2026)
1.2.5.6. Middle East and Africa (MEA) Immunohistochemistry (IHC) Market Revenue and Growth Rate (2015-2026)

CHAPTER 2. MARKET DYNAMICS AND COMPETITION ANALYSIS

2.1. Market Drivers
2.2. Restraints and Challenges
2.3. Growth Opportunities
2.4. Porter's Five Forces Analysis
2.4.1. Bargaining Power of Suppliers
2.4.2. Bargaining Power of Buyers
2.4.3. Threat of Substitute
2.4.4. Threat of New Entrants
2.4.5. Degree of Competition
2.5. Value Chain Analysis
2.6. Cost Structure Analysis
2.6.1. Raw Material and Suppliers
2.6.2. Manufacturing Process Analysis
2.7. Regulatory Compliance
2.8. Competitive Landscape, 2017
2.8.1. Player Positioning Analysis
2.8.2. Key Strategies Adopted By Leading Players

CHAPTER 3. MANUFACTURING PLANTS ANALYSIS

3.1. Capacity and Commercial Production Date of Global Immunohistochemistry (IHC) Major Manufacturers in 2017
3.2. Manufacturing Plants Distribution of Global Immunohistochemistry (IHC) Major Manufacturers in 2017
3.3. R&D Status and Technology Source of Global Immunohistochemistry (IHC) Major Manufacturers in 2017
3.4. Raw Materials Sources Analysis of Global Immunohistochemistry (IHC) Major Manufacturers in 2017

CHAPTER 4. IMMUNOHISTOCHEMISTRY (IHC) MARKET BY PRODUCT

4.1. Global Immunohistochemistry (IHC) Revenue By Product
4.2. Antibodies
4.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.3. Equipment
4.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.4. Reagents
4.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.5. Kits
4.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.6. Other
4.6.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.6.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 5. IMMUNOHISTOCHEMISTRY (IHC) MARKET BY APPLICATION

5.1. Global Immunohistochemistry (IHC) Revenue By Application
5.2. Diagnostics
5.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.3. Drug Testing
5.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.4. Others
5.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 6. IMMUNOHISTOCHEMISTRY (IHC) MARKET BY END USERS

6.1. Global Immunohistochemistry (IHC) Revenue By End Users
6.2. Hospitals and Diagnostic Laboratories
6.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.3. Research Institutes
6.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.4. Others
6.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 7. NORTH AMERICA IMMUNOHISTOCHEMISTRY (IHC) MARKET BY COUNTRY

7.1. North America Immunohistochemistry (IHC) Market Revenue and Growth Rate, 2015 - 2026 ($Million)
7.2. North America Immunohistochemistry (IHC) Market Revenue Share Comparison, 2015 & 2026 (%)
7.3. U.S.
7.3.1. U.S. Immunohistochemistry (IHC) Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
7.3.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
7.3.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)
7.4. Canada
7.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
7.4.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
7.4.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)
7.5. Mexico
7.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
7.5.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
7.5.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)

CHAPTER 8. EUROPE IMMUNOHISTOCHEMISTRY (IHC) MARKET BY COUNTRY

8.1. Europe Immunohistochemistry (IHC) Market Revenue and Growth Rate, 2015 - 2026 ($Million)
8.2. Europe Immunohistochemistry (IHC) Market Revenue Share Comparison, 2015 & 2026 (%)
8.3. UK
8.3.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
8.3.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
8.3.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)
8.4. Germany
8.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
8.4.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
8.4.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)
8.5. France
8.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
8.5.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
8.5.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)
8.6. Spain
8.6.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
8.6.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
8.6.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)
8.7. Rest of Europe
8.7.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
8.7.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
8.7.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)

CHAPTER 9. ASIA-PACIFIC IMMUNOHISTOCHEMISTRY (IHC) MARKET BY COUNTRY

9.1. Asia-Pacific Immunohistochemistry (IHC) Market Revenue and Growth Rate, 2015 - 2026 ($Million)
9.2. Asia-Pacific Immunohistochemistry (IHC) Market Revenue Share Comparison, 2015 & 2026 (%)
9.3. China
9.3.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
9.3.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
9.3.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)
9.4. Japan
9.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
9.4.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
9.4.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Mi+llion)
9.5. India
9.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
9.5.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
9.5.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)
9.6. Australia
9.6.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
9.6.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
9.6.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)
9.7. South Korea
9.7.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
9.7.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
9.7.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)
9.8. Rest of Asia-Pacific
9.8.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
9.8.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
9.8.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)

CHAPTER 10. LATIN AMERICA IMMUNOHISTOCHEMISTRY (IHC) MARKET BY COUNTRY

10.1. Latin America Immunohistochemistry (IHC) Market Revenue and Growth Rate, 2015 - 2026 ($Million)
10.2. Latin America Immunohistochemistry (IHC) Market Revenue Share Comparison, 2015 & 2026 (%)
10.3. Brazil
10.3.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
10.3.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
10.3.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)
10.4. Argentina
10.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
10.4.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
10.4.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)
10.5. Rest of Latin America
10.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
10.5.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
10.5.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)

CHAPTER 11. MIDDLE EAST IMMUNOHISTOCHEMISTRY (IHC) MARKET BY COUNTRY

11.1. Middle East Immunohistochemistry (IHC) Market Revenue and Growth Rate, 2015 - 2026 ($Million)
11.2. Middle East Immunohistochemistry (IHC) Market Revenue Share Comparison, 2015 & 2026 (%)
11.3. Saudi Arabia
11.3.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
11.3.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
11.3.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)
11.4. UAE
11.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
11.4.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
11.4.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)
11.5. Rest of Middle East
11.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
11.5.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
11.5.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)

CHAPTER 12. AFRICA IMMUNOHISTOCHEMISTRY (IHC) MARKET BY COUNTRY

12.1. Africa Immunohistochemistry (IHC) Market Revenue and Growth Rate, 2015 - 2026 ($Million)
12.2. Africa Immunohistochemistry (IHC) Market Revenue Share Comparison, 2015 & 2026 (%)
12.3. South Africa
12.3.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
12.3.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
12.3.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)
12.4. Egypt
12.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
12.4.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
12.4.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)
12.5. Rest of Africa
12.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
12.5.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
12.5.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)

CHAPTER 13. COMPANY PROFILE

13.1. F. Hoffmann-La Roche AG
13.1.1. Company Snapshot
13.1.2. Overview
13.1.3. Financial Overview
13.1.4. Type Portfolio
13.1.5. Key Developments
13.1.6. Strategies
13.2. Abcam plc
13.2.1. Company Snapshot
13.2.2. Overview
13.2.3. Financial Overview
13.2.4. Type Portfolio
13.2.5. Key Developments
13.2.6. Strategies
13.3. Thermo Fisher Scientific, Inc.
13.3.1. Company Snapshot
13.3.2. Overview
13.3.3. Financial Overview
13.3.4. Type Portfolio
13.3.5. Key Developments
13.3.6. Strategies
13.4. Agilent Technologies
13.4.1. Company Snapshot
13.4.2. Overview
13.4.3. Financial Overview
13.4.4. Type Portfolio
13.4.5. Key Developments
13.4.6. Strategies
13.5. PerkinElmer, Inc.
13.5.1. Company Snapshot
13.5.2. Overview
13.5.3. Financial Overview
13.5.4. Type Portfolio
13.5.5. Key Developments
13.5.6. Strategies
13.6. Bio SB
13.6.1. Company Snapshot
13.6.2. Overview
13.6.3. Financial Overview
13.6.4. Type Portfolio
13.6.5. Key Developments
13.6.6. Strategies
13.7. Merck KGaA
13.7.1. Company Snapshot
13.7.2. Overview
13.7.3. Financial Overview
13.7.4. Type Portfolio
13.7.5. Key Developments
13.7.6. Strategies
13.8. Bio-Rad Laboratories, Inc.
13.8.1. Company Snapshot
13.8.2. Overview
13.8.3. Financial Overview
13.8.4. Type Portfolio
13.8.5. Key Developments
13.8.6. Strategies
13.9. Danaher Corporation
13.9.1. Company Snapshot
13.9.2. Overview
13.9.3. Financial Overview
13.9.4. Type Portfolio
13.9.5. Key Developments
13.9.6. Strategies
13.10. Cell Signaling Technology, Inc.
13.10.1. Company Snapshot
13.10.2. Overview
13.10.3. Financial Overview
13.10.4. Type Portfolio
13.10.5. Key Developments
13.10.6. Strategies
13.11. Others
13.11.1. Company Snapshot
13.11.2. Overview
13.11.3. Financial Overview
13.11.4. Type Portfolio
13.11.5. Key Developments
13.11.6. Strategies

CHAPTER 14. RESEARCH APPROACH

14.1. Research Methodology
14.1.1. Initial Data Search
14.1.2. Secondary Research
14.1.3. Primary Research
14.2. Assumptions and Scope

INQUIRY BEFORE BUYING@ https://www.acumenresearchandconsulting.com/inquiry-before-buying/1118

The report is readily available and can be dispatched immediately after payment confirmation.

Buy this premium research report – https://www.acumenresearchandconsulting.com/buy-now/0/1118

Would like to place an order or any question, please feel free to contact at sales@acumenresearchandconsulting.com | +1 407 915 4157

About Acumen Research and Consulting
Acumen Research and Consulting (ARC) is a global provider of market intelligence and consulting services to information technology, investment, telecommunication, manufacturing, and consumer technology markets. ARC helps investment communities, IT professionals, and business executives to make fact based decisions on technology purchases and develop firm growth strategies to sustain market competition. With the team size of 100+ Analysts and collective industry experience of more than 200 years, Acumen Research and Consulting assures to deliver a combination of industry knowledge along with global and country level expertise.